Recent Work
-
USC Research Shows Costco Beats Medicare in Generic Drug Savings Nearly 50% of the Time
Intermediaries negotiate good prices, but lack incentives to pass savings to beneficiaries and taxpayers.
Categorized in -
Experts at Schaeffer-Aspen Webinar Discuss Modernizing Health Technology Assessment in the U.S.
The U.S. does not have a coordinated process to evaluate the effectiveness and value of new devices, medicines or procedures. Schaeffer Center and the Aspen Institute hosted a panel discussion on the viability of an Institute of Health Technology Assessment.
-
Precision Medicine: Moving Theory into Practice
Over a four-part webinar series, Schaeffer Center will bring together experts to discuss how we can move precision medicine from theory to practice.
-
Developing Effective Payment and Reimbursement Models
Targeted therapies can come with significant costs. But successful use of personalized medicine can also result in better healthcare outcomes and reduced long-term costs over time. Given this, how we pay for these therapies may require new approaches and models.
-
Measuring Real-World Effectiveness and Value
Precision therapies are often approved based on small trials, in specialized settings, and using biomarkers as endpoints. Thus, despite their potential high cost, the evidence of value is lacking which makes real-world evidence crucial.